Cathepsin cysteine protease inhibitors

Details for Australian Patent Application No. 2003266052 (hide)

Owner Merck Frosst Canada Ltd.

Inventors Mellon, Christophe; Lau, Cheuk; Gagnon, Marc; Scheigetz, John; Boyd, Michael

Agent Spruson & Ferguson

Pub. Number AU-B-2003266052

PCT Number PCT/CA03/01346

PCT Pub. Number WO2004/022526

Priority 60/408,064 04.09.02 US

Filing date 3 September 2003

Wipo publication date 29 March 2004

Acceptance publication date 23 April 2009

International Classifications

C07D 295/08 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/275 (2006.01) - Nitriles

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/404 (2006.01)

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/4439 (2006.01)

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/47 (2006.01) - Quinolines

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/497 (2006.01)

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61K 31/69 (2006.01) - Boron compounds

A61K 31/695 (2006.01) - Silicon compounds

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/02 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/14 (2006.01) Drugs for disorders of the metabolism

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

18 December 2003 Complete Application Filed

  Priority application(s): 60/408,064 04.09.02 US

13 May 2004 Application Open to Public Inspection

  Published as AU-B-2003266052

16 March 2006 Assignment before Grant

  Merck Frosst Canada & Co. The application has been assigned to Merck Frosst Canada Ltd.

23 April 2009 Application Accepted

  Published as AU-B-2003266052

20 August 2009 Standard Patent Sealed

29 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003266053-SYSTEM AND METHOD FOR POWER LOAD MANAGEMENT

2003266051-COMBINED LIQUEFIED GAS AND COMPRESSED GAS RE-FUELING STATION AND METHOD OF OPERATING SAME